Influence of tumor derived fibroblasts and 1,25-dihydroxyvitamin D3 on growth of breast cancer cell lines M. F. LefebvreC. GuillotS. Saez Report Pages: 189 - 197
Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies E. RønneG. Høyer-HansenJ. Grøndahl-Hansen Report Pages: 199 - 207
Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen:31P NMR studies Jesús Ruiz-CabelloKirsten BerghmansJack S. Cohen Report Pages: 209 - 217
Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast Rosalba TorrisiSilvia ZanardiFrancesco Boccardo Report Pages: 219 - 224
Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin Huei-Shien ChiangMark W. SwaimTur-Fu Huang Report Pages: 225 - 235
Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat Fernand LabrieShengmin LiYves Mérand Report Pages: 237 - 244
Protein tyrosine phosphatase activity as a diagnostic parameter in breast cancer Astrid E. Ottenhoff-KalffBrigitte A. van OirschotGert Rijksen Report Pages: 245 - 256
Hypotheses: Melatonin/steroid combination contraceptives will prevent breast cancer Michael CohenRuby Ann SmallAmnon Brzezinski Hypotheses Pages: 257 - 264
Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: Results of a multicentric phase II trial Domenico AmorosoFrancesco BoccardoMario Mesiti Brief communication Pages: 265 - 268
Relationship between staining by digital subtraction angiography and vascularity in breast cancer: Analysis of the time-density curve and the results of staining for factor VIII-related antigen/von Willebrand factor Osamu WatanabeShunsuke HagaMariko Fujibayashi Brief communication Pages: 269 - 273
